Patents by Inventor Wenjun Huang

Wenjun Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250090233
    Abstract: Disclosed are a method, an apparatus, and an electronic device for determining a heart valve based on multiple planes. The method includes steps of: determining a plurality of target planes in a heart based on an anatomical image; determining at least one first initial pushing point located on an inner contour line of a heart valve leaflet in each target plane; determining at least one first pushing reach point corresponding to the at least one first initial pushing point; determining at least one first pushing range of each target plane based on the at least one first pushing reach point; determining a second pushing range of the heart valve based on the at least one first pushing range; and determining an artificial heart valve that matches the heart valve based on the second pushing range.
    Type: Application
    Filed: December 2, 2024
    Publication date: March 20, 2025
    Inventors: Wenjun Huang, Wei Chen, Xu Zhao, Xiaotong Zeng, Xiaodong Zhan, Wenwen Wu
  • Patent number: 12102633
    Abstract: Provided herein are spirolactone compounds of Formula I that are useful as inhibitors of ACC1 and/or ACC2. The spirolactone compounds described herein can be used for treating a disease or disorder associated with aberrant ACC1 and/or ACC2 activities, for example, non-alcoholic steatohepatitis (NASH), acne, obesity, diabetes, and cancer. Also provided herein are pharmaceutical compositions comprising the spirolactone compound of Formula I, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: January 3, 2023
    Date of Patent: October 1, 2024
    Assignee: Quixgen, Inc.
    Inventors: Yusheng Xiong, Hong-Ping Guan, Wenjun Huang
  • Publication number: 20240113068
    Abstract: A method for forming an ultrafine-pitch all-copper interconnect structure is provided. Nano-copper particles are mixed with a solvent, a dispersant and a viscosity modifier to prepare a nano-copper paste. A chip with a preset number of copper pillars having a preset diameter and a substrate are selected, cleaned and pretreated. The chip is sucked and flipped by a bonding machine to make the copper pillars face outward. The chip is sucked through a suction nozzle of the bonding machine and dipped in the nano-copper paste. A protective gas is fed, and the copper pillars are aligned with copper pads on the substrate through an optical system of the bonding machine, bonded with the substrate at a preset pressure and temperature under ultrasonication, and cooled at room temperature to obtain the interconnect structure. An ultrafine-pitch all-copper interconnect structure fabricated by the method is also provided.
    Type: Application
    Filed: November 2, 2023
    Publication date: April 4, 2024
    Inventors: Yu ZHANG, Ranyuan ZHANG, Junyu HE, Wenjun HUANG, Chengqiang CUI, Guannan YANG
  • Publication number: 20240083994
    Abstract: Provided are a cell strain for producing a biosimilar drug of Ustekinumab and a production method therefor. Specifically, provided is a Chinese hamster ovary cell S cell strain. The cell strain expresses a full human monoclonal antibody directed against the P40 subunit shared by human IL-12 and human IL-23. The fully human monoclonal antibody directed against the P40 subunit shared by human IL-12 and human IL-23 is a biosimilar drug of Ustekinumab, which not only exhibits high consistency with Ustekinumab in pre-clinical research, but also passes pharmacokinetic bioequivalence and safety similarity evaluation in clinical research. The biosimilar drug of Ustekinumab is the first one that has entered clinical trials in China, is the only one that has completed the I stage clinical trial, and is also one of the biosimilar drugs of Ustekinumab, which has the fastest progress in new drug application in the world.
    Type: Application
    Filed: March 23, 2021
    Publication date: March 14, 2024
    Applicant: QYUNS THERAPEUTICS CO., LTD.
    Inventors: Zhengxue XU, Tao LI, Yin CHEN, Wenjun HUANG, Yi WANG, Huaiyao QIAO, Min FANG, Yiliang WU, Mengdan ZHANG
  • Publication number: 20230355609
    Abstract: Provided herein are spirolactone compounds of Formula I that are useful as inhibitors of ACC1 and/or ACC2. The spirolactone compounds described herein can be used for treating a disease or disorder associated with aberrant ACC1 and/or ACC2 activities, for example, non-alcoholic steatohepatitis (NASH), acne, obesity, diabetes, and cancer. Also provided herein are pharmaceutical compositions comprising the spirolactone compound of Formula I, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 3, 2023
    Publication date: November 9, 2023
    Applicant: Quixgen, Inc.
    Inventors: Yusheng Xiong, Hong-Ping Guan, Wenjun Huang
  • Patent number: 11608732
    Abstract: Certain aspects and features relate to a system that includes a drilling tool, a processor, and a non-transitory memory device that includes instructions that are executable by the processor to cause the processor to perform operations. The operations include receiving input data that corresponds to characteristics of at least one of drilling fluid, a drillstring, or a wellbore. The operations also include calculating at least one dynamic sideforce and at least one dynamic, hydraulic force based at least in part on the input data. The operations also include determining an equilibrium solution for an output value using the at least one dynamic sideforce and at least one dynamic, hydraulic force. The operations also include applying the output value to the drilling tool for controlling operation of the drilling tool.
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: March 21, 2023
    Assignee: Landmark Graphics Corporation
    Inventors: Robello Samuel, Wenjun Huang
  • Patent number: 11541046
    Abstract: Provided herein are spirolactone compounds of Formula I that are useful as inhibitors of ACC1 and/or ACC2. The spirolactone compounds described herein can be used for treating a disease or disorder associated with aberrant ACC1 and/or ACC2 activities, for example, non-alcoholic steatohepatitis (NASH), acne, obesity, diabetes, and cancer. Also provided herein are pharmaceutical compositions comprising the spirolactone compound of Formula I, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: January 3, 2023
    Assignee: Quixgen, Inc.
    Inventors: Yusheng Xiong, Hong-Ping Guan, Wenjun Huang
  • Publication number: 20220243576
    Abstract: Certain aspects and features relate to a system that includes a drilling tool, a processor, and a non-transitory memory device that includes instructions that are executable by the processor to cause the processor to perform operations. The operations include receiving input data that corresponds to characteristics of at least one of drilling fluid, a drillstring, or a wellbore. The operations also include calculating at least one dynamic sideforce and at least one dynamic, hydraulic force based at least in part on the input data. The operations also include determining an equilibrium solution for an output value using the at least one dynamic sideforce and at least one dynamic, hydraulic force. The operations also include applying the output value to the drilling tool for controlling operation of the drilling tool.
    Type: Application
    Filed: April 26, 2022
    Publication date: August 4, 2022
    Inventors: Robello Samuel, Wenjun Huang
  • Patent number: 11326438
    Abstract: Certain aspects and features relate to a system that selects an output value for controlling a drilling tool using dynamic force analysis coupled to fluid effects as part of a model that estimates projected torque and drag. A drilling model according to aspects and features of the present disclosure takes into account pipe axial elasticity as it relates to dynamic, time-based, force analysis and couples this relationship with drilling fluid effects over time. In some examples, a system calculates at least one dynamic sideforce and at least one dynamic, hydraulic force for each interval of time. An equilibrium solution for an output value using the dynamic sideforce and dynamic, hydraulic force for each time interval can be applied to the drilling tool for each time interval during drilling operations.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: May 10, 2022
    Assignee: Landmark Graphics Corporalion
    Inventors: Robello Samuel, Wenjun Huang
  • Publication number: 20210404318
    Abstract: Certain aspects and features relate to a system that selects an output value for controlling a drilling tool using dynamic force analysis coupled to fluid effects as part of a model that estimates projected torque and drag. A drilling model according to aspects and features of the present disclosure takes into account pipe axial elasticity as it relates to dynamic, time-based, force analysis and couples this relationship with drilling fluid effects over time. In some examples, a system calculates at least one dynamic sideforce and at least one dynamic, hydraulic force for each interval of time. An equilibrium solution for an output value using the dynamic sideforce and dynamic, hydraulic force for each time interval can be applied to the drilling tool for each time interval during drilling operations.
    Type: Application
    Filed: July 30, 2019
    Publication date: December 30, 2021
    Inventors: Robello Samuel, Wenjun Huang
  • Publication number: 20210145822
    Abstract: Provided herein are spirolactone compounds of Formula I that are useful as inhibitors of ACC1 and/or ACC2. The spirolactone compounds described herein can be used for treating a disease or disorder associated with aberrant ACC1 and/or ACC2 activities, for example, non-alcoholic steatohepatitis (NASH), acne, obesity, diabetes, and cancer. Also provided herein are pharmaceutical compositions comprising the spirolactone compound of Formula I, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 29, 2018
    Publication date: May 20, 2021
    Applicant: Quixgen, Inc.
    Inventors: Yusheng Xiong, Hong-Ping Guan, Wenjun Huang
  • Publication number: 20190198422
    Abstract: The present disclosure discloses a semiconductor apparatus and method of manufacturing. The apparatus includes: a circuit device and a heat sink fin that are disposed in a laminated manner, and a thermal interface material layer located between the circuit device and the heat sink fin. A packaging layer is disposed around a side wall of the circuit device. A first surface of the thermal interface material layer is thermally coupled to the circuit device and the packaging layer, and a second surface is thermally coupled to the heat sink fin. In the foregoing solution, the packaging layer and the circuit device are both thermally coupled to the thermal interface material layer, a contact area between the circuit device and the thermal interface material layer is increased.
    Type: Application
    Filed: February 27, 2019
    Publication date: June 27, 2019
    Inventors: Jyh Rong LIN, Wenjun HUANG
  • Patent number: 9014523
    Abstract: A large mode field active optical fiber and manufacture method thereof is provided. The large mode field active optical fiber is formed by drawing a fiber core (1), a quartz glass internal cladding (2), a quartz glass outer cladding (3), and a coating (4). The quartz glass internal cladding (2), the quartz glass outer cladding (3), and the coating (4) are sequentially coated on the outer surface of the fiber core (1). The fiber core (1) is formed by depositing, melting, and shrinking the tetrachlorosilane doped with rare earth ions in a quartz glass tube. The refractive index of the fiber core (1) is a graded refractive index, and the section parameter a thereof is 1???3. The appearance of the quartz glass inner cladding (2) is regular multi-prism shaped.
    Type: Grant
    Filed: November 24, 2010
    Date of Patent: April 21, 2015
    Assignee: Fiberhome Telecommunications Technologies Co., Ltd.
    Inventors: Wei Chen, Shiyu Li, Daoyu Lei, Dongxiang Wang, Wenyong Luo, Wenjun Huang, Fuming Hu, Peng Hu
  • Publication number: 20120263428
    Abstract: A large mode field active optical fiber and manufacture method thereof is provided. The large mode field active optical fiber is formed by drawing a fiber core (1), a quartz glass internal cladding (2), a quartz glass outer cladding (3), and a coating (4). The quartz glass internal cladding (2), the quartz glass outer cladding (3), and the coating (4) are sequentially coated on the outer surface of the fiber core (1). The fiber core (1) is formed by depositing, melting, and shrinking the tetrachlorosilane doped with rare earth ions in a quartz glass tube. The refractive index of the fiber core (1) is a graded refractive index, and the section parameter a thereof is 1???3. The appearance of the quartz glass inner cladding (2) is regular multi-prism shaped.
    Type: Application
    Filed: November 24, 2010
    Publication date: October 18, 2012
    Inventors: Wei Chen, Shiyu Li, Daoyu Lei, Dongxiang Wang, Wenyong Luo, Wenjun Huang, Fuming Hu, Peng Hu